SCHEMBL18929424

SCHEMBL18929424

C=C(N)c1ccc(-c2cnn(Cc3cccc(C(=O)NC)c3)c2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.49
▸ CCNC P24863 2/20 0.46
▸ CDK8 P49336 2/20 0.46
▸ KLKB1 P03952 5/20 0.45
▸ L3MBTL1 Q9Y468 2/20 0.45
▸ POLB P06746 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.45
▸ TSHR P16473 2/20 0.44
▸ LMNA P02545 1/20 0.44
▸ SLC7A5 Q01650 1/20 0.44
▸ ALK Q9UM73 1/20 0.44
▸ NAMPT P43490 1/20 0.43
▸ HPGD P15428 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17790720 0.83 ROCK2 (0.57) KDM4ECCNCCDK8KLKB1L3MBTL1
SCHEMBL13555495 0.73 L3MBTL1 (0.58) KDM4EL3MBTL1POLBTDP1SLC7A5
SCHEMBL2713277 0.71 CREBBP (0.55) KDM4EKLKB1L3MBTL1POLBTDP1
SCHEMBL28655081 0.71 FGFR1 (0.53) CCNCCDK8L3MBTL1NAMPTRAB9A
SCHEMBL22557105 0.71 ALDH1A1 (0.55) KDM4EKLKB1HPGDALDH1A1
SCHEMBL2712569 0.70 L3MBTL1 (0.60) KLKB1L3MBTL1POLBTDP1ALK
SCHEMBL3713180 0.69 L3MBTL1 (0.62) KLKB1L3MBTL1POLBTDP1ALK
SCHEMBL29778420 0.68 WNT1 (0.51) CCNCCDK8ALKROCK2
SCHEMBL29135953 0.68 WNT1 (0.51) CCNCCDK8ALKROCK2
SCHEMBL14699418 0.67 KLKB1 (0.60) KDM4EKLKB1L3MBTL1POLBTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3016950-B1 TRICYCLIC PYRIDO-CARBOXAMIDE DERIVATIVES AS ROCK INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2017-06-07 — — EP disclosed
Send feedback